3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Endocrine
1
Conditions
Neuroendocrine Tumors
4
Carcinoma, Neuroendocrine
2
Serotonin Syndrome
1
Paraganglioma
1
Neoplasm Metastasis
1
Carcinoid Tumor
1
Carcinoid Heart Disease
1
Interventions
recombinant interferon alpha 2b-like protein
1
lutetium Lu 177 dotatate
1
lanreotide
1
Sunitinib
1
Rose Bengal
1
Injections
1
Everolimus
1
Biological Factors
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Carcinoid Tumor
×
lutetium Lu 177 dotatate
×
Clear all
NCT04039516
2020-08-04
CHARRT
King's College Hospital NHS Trust
Phase 2
Unknown
20 enrolled